MENU
FDMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

4D Molecular Therapeutics (FDMT) Ownership - Who owns 4D Molecular Therapeutics?

Profile

Industry
N/A
Address
5858 Horton Street
Phone
+1 510 505-2680
Employees
147
Web
https://www.4dmoleculartherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
299.56M
P/E Ratio
N/A
Total Cash
501.89M
Projected Growth
N/A
Total Debt
24.83M
Revenue
17K
Risk (Beta)
3.12
Dividend Yield
N/A
Total Cash/Share
10.86
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price

Fundamentals

FDMT
Capitalization
300M
P/E Ratio
N/A
Risk (Beta)
3.12
Dividend Yield
N/A
Total Cash
502M
Total Cash/Share
10.86
Total Debt
24.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
17K
ROE
N/A
Book Value
553M
P/B Ratio
0.53
Cash Flow
N/A
Earnings
-2.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
17.33
Current Revenue Per Employee
14.93
Dividends Per Share - Security
N/A
EBITDA
-161.94M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.72
Shares Held By Institutions
1.42B
Shares Outstanding - Current
46.2M
Total Liabilities
51.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
-68.806
View a ticker or compare two or three
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5858 Horton Street
Phone
+1 510 505-2680
Employees
147
Web
https://www.4dmoleculartherapeutics.com